- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
When using Selpercatinib, special attention should be paid to adverse reactions such as liver toxicity, interstitial lung disease, and hyperten...
Selpercatinib is suitable for cancer patients with specific gene mutations, and its use must strictly follow genetic testing results and specia...
Selpercatinib is a RET kinase inhibitor used to treat RET fusion positive non-small cell lung cancer, thyroid cancer, and other malignant tumor...
The side effects of Selpercatinib can be divided into severe reactions that require urgent treatment and common reactions that can be self reli...
Letermovir is a novel anti cytomegalovirus (CMV) drug that inhibits the virus terminating enzyme complex through a unique mechanism. It is main...
The side effects of Letermovir mainly include blood system abnormalities, digestive system reactions, and drug interaction risks, and its mitig...
Gilteritinib is an FLT3 tyrosine kinase inhibitor primarily used to treat relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutatio...
The side effects of Gilteritinib include blood system abnormalities, cardiac toxicity, and special organ damage, and its relief methods include...
Cabergoline is a dopamine D2 receptor agonist mainly used to treat hyperprolactinemia and related diseases. Its dosage needs to be gradually ...
The side effects of Cabergoline can be classified into severe reactions that require immediate medical attention, common reactions that may sel...
